CH629479A5 - Derives de la taurine, medicament contenant ces derives et procede de preparation de ces derives. - Google Patents

Derives de la taurine, medicament contenant ces derives et procede de preparation de ces derives. Download PDF

Info

Publication number
CH629479A5
CH629479A5 CH312778A CH312778A CH629479A5 CH 629479 A5 CH629479 A5 CH 629479A5 CH 312778 A CH312778 A CH 312778A CH 312778 A CH312778 A CH 312778A CH 629479 A5 CH629479 A5 CH 629479A5
Authority
CH
Switzerland
Prior art keywords
derivatives
acetyltaurinate
equal
derivative according
taurine
Prior art date
Application number
CH312778A
Other languages
English (en)
French (fr)
Inventor
Jean Pierre Durlach
Original Assignee
Meram Les Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meram Les Laboratoires filed Critical Meram Les Laboratoires
Publication of CH629479A5 publication Critical patent/CH629479A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH312778A 1977-03-23 1978-03-22 Derives de la taurine, medicament contenant ces derives et procede de preparation de ces derives. CH629479A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7708692A FR2384751A1 (fr) 1977-03-23 1977-03-23 Nouveaux derives de la taurine a activite neuro-musculaire renforcee

Publications (1)

Publication Number Publication Date
CH629479A5 true CH629479A5 (fr) 1982-04-30

Family

ID=9188473

Family Applications (1)

Application Number Title Priority Date Filing Date
CH312778A CH629479A5 (fr) 1977-03-23 1978-03-22 Derives de la taurine, medicament contenant ces derives et procede de preparation de ces derives.

Country Status (17)

Country Link
US (3) US4199601A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS53149928A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT356637B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU523705B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE865163A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1095930A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH629479A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2810918C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES468201A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2384751A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1599962A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR62093B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1111455B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7803131A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA05914A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE443781B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA781697B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457281A1 (fr) 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
US5602150A (en) * 1992-10-02 1997-02-11 Research Foundation For Mental Hygiene, Inc. Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia
US6099869A (en) * 1995-04-18 2000-08-08 Nutrition 21 Calcium taurate and antihypertensive drug for hypertension
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
SI1051393T1 (en) * 1998-01-27 2004-02-29 Merck Sante New derivatives of sulfonic, phosphonic and phosphinic aminoalkane acids, their production and their use as medicaments
JP4726304B2 (ja) * 1999-04-28 2011-07-20 ベルス ヘルス （インターナショナル） リミティッド アミロイドーシスを治療するための組成物および方法
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US6881750B2 (en) * 2003-03-04 2005-04-19 Nutrition Corp. Of America, Ltd. Potassium taurate bicarbonate and ascorbate
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
EP1828111A2 (en) * 2004-11-12 2007-09-05 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
AU2005310979A1 (en) * 2004-11-16 2006-06-08 Bellus Health (International) Limited Compounds for the treatment of CNS and amyloid associated diseases
FR2878160B1 (fr) * 2004-11-19 2008-07-25 Jean Pierre Durlach Utilisation du n-acetyl-taurinate de magnesium pour la preparation de medicaments inhibiteurs de l'hypersensiblite photique
EP1836161B1 (en) * 2004-12-22 2016-07-20 BHI Limited Partnership Methods and compositions for treating amyloid-related diseases
PL3851447T3 (pl) 2006-10-12 2024-03-04 Bellus Health Inc. Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy
EP2217564A1 (en) * 2007-09-07 2010-08-18 XenoPort, Inc. Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090082464A1 (en) * 2007-09-07 2009-03-26 Bernd Jandeleit Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
TW200932734A (en) * 2007-10-15 2009-08-01 Xenoport Inc Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
FR2927809B1 (fr) 2008-02-26 2011-01-14 Tri Inov Nouvelle utilisation de n-acetyl-taurinate de zinc.
RU2453310C1 (ru) * 2010-12-09 2012-06-20 Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ") Средство, обладающее нейропротекторным действием в условиях ишемического поражения мозга и гипоксии, представляющее собой 2-аминоэтансульфонат магния, фармацевтические композиции
FR2973702B1 (fr) 2011-04-08 2013-04-26 Tri Inov N-acetyl-taurinate de zinc pour le traitement du cancer de la prostate
AU2012343935A1 (en) * 2011-11-29 2014-07-03 Basf Se Method for producing and purifying salts of acrylamido-2-methylpropane sulfonic acid
EP3310366A4 (en) 2015-06-17 2019-01-02 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
CN106913561B (zh) * 2015-12-25 2020-12-15 北京乳凝创智生物技术研发中心（有限合伙） 牛磺酸螯合钙在制备经皮吸收制剂中的应用
BE1025644B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement d'une maladie ou d'un trouble du systeme nerveux central chez un sujet en stimulant et/ou en restaurant la plasticite neuronale
BE1025645B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement de la neurotoxicite due a l'hyperexcitabilite des recepteurs glutamatergiques ionotropes
EP3738588A1 (en) 2019-05-13 2020-11-18 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for use in the treatment of rosacea
EP3738596B1 (fr) 2019-05-16 2022-03-16 Synapharm Industrial Synthesis Composé et composition pour utilisation dans le traitement du syndrome prémenstruel et/ou du trouble dysphorique prémenstruel
MX2021013851A (es) 2019-05-16 2022-01-07 Synapharm Ind Synthesis Compuesto y composicion para el uso en el tratamiento del sindrome premenstrual y/o trastorno disforico premenstrual.
BE1026955B1 (fr) * 2019-06-11 2020-08-04 Synapharm Ind Synthesis Procédé de fabrication de N-acétyl-taurinate de magnésium
RU2731106C1 (ru) * 2019-10-23 2020-08-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Дикалиевая соль N-(4-гидроксибензоил)таурина, обладающая антиагрегантной и антитромботической активностью
RU2730835C1 (ru) * 2019-10-23 2020-08-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Дикалиевая соль N-(3-гидроксибензоил)таурина, обладающая антиагрегантной и антитромботической активностью в сочетании с церебропротективным действием
US11376277B2 (en) 2020-06-01 2022-07-05 Celagenex Research (India) Pvt. Ltd. Synergistic medicinal compositions for treating dysfunctional D-serine signaling
CN119504517B (zh) * 2025-01-22 2025-04-18 浙江天启生化股份有限公司 一种乙酰牛磺酸镁的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232968A (en) * 1959-12-01 1966-02-01 Gen Aniline & Film Corp Process for preparing n-acyl taurates using hypophosphorous acid as catalyst
US3344174A (en) * 1962-08-21 1967-09-26 Monsanto Co Vicinal acylamido sulfonate compounds
DE1256650B (de) * 1965-08-07 1967-12-21 Dr Dieter Arlt Verfahren zur Herstellung von N-acylierten 2-Amino-alkan-sulfonsaeuren-(1) bzw. von 2-Amino-alkan-sulfonsaeuren-(1)
US3544597A (en) * 1969-06-12 1970-12-01 Rohm & Haas Process for manufacturing sulfonated amides
US3960918A (en) * 1973-06-26 1976-06-01 The Lubrizol Corporation Preparation of esters of amidoalkanesulfonic acids

Also Published As

Publication number Publication date
BE865163A (fr) 1978-09-22
GR62093B (en) 1979-02-22
SE443781B (sv) 1986-03-10
IT1111455B (it) 1986-01-13
FR2384751B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-07-20
NL7803131A (nl) 1978-09-26
DE2810918C2 (de) 1985-06-20
GB1599962A (en) 1981-10-07
JPS6256867B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-11-27
JPS53149928A (en) 1978-12-27
ZA781697B (en) 1979-03-28
CA1095930A (en) 1981-02-17
US4267194A (en) 1981-05-12
US4199601A (en) 1980-04-22
OA05914A (fr) 1981-06-30
AT356637B (de) 1980-05-12
ES468201A1 (es) 1978-12-01
AU523705B2 (en) 1982-08-12
IT7867631A0 (it) 1978-03-22
ATA202878A (de) 1979-10-15
SE7803032L (sv) 1978-09-24
AU3463478A (en) 1979-10-04
FR2384751A1 (fr) 1978-10-20
US4271189A (en) 1981-06-02
DE2810918A1 (de) 1978-09-28

Similar Documents

Publication Publication Date Title
CH629479A5 (fr) Derives de la taurine, medicament contenant ces derives et procede de preparation de ces derives.
EP0233106B1 (fr) (-)-Benzhydrylsulfinylacétamide, procédé de préparation et utilisation en thérapeutique
CA1103676A (fr) Procede de preparation de nouveaux derives du piperidyl-indole et leurs sels
CH639653A5 (fr) Aminothiazoles et composition pharmaceutique les contenant.
FR2502153A1 (fr) Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant
CA1134371A (fr) Derives de pyrrolidine-2 methanol utilisables comme medicaments
CA1312333C (fr) Sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
DE3446887A1 (de) Verfahren zur herstellung eines neuen haeminkomplexes
EP0445025A2 (fr) Nouveaux sels de métaux alcalinoterreux d'oxa-polyacides leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
BE1003959A5 (fr) Agent therapeutique pour le traitement de troubles associes a l'ischemie cerebrale.
CH651032A5 (fr) Phenoxyisobutyrates de moroxydine et medicaments les contenant.
JPH09301882A (ja) 抗糖尿病剤及びその製造法
WO2002012177A1 (en) Composition of metformin with succinic acid or salts thereof and method for treating diabetes
CH624922A5 (en) Process for the preparation of new methylamine derivatives
CH646182A5 (fr) Derive du 5-pregnan-20-ol et ses sels avec les acides, leur preparation et medicaments les renfermant.
EP0073711B1 (fr) Sels de l'acide 2-oxo-1,5-pentane dioique, leur procédé de fabrication et médicaments renfermant ces sels
FR2517542A1 (fr) Medicament pour l'amelioration du metabolisme lipidique
BE828694R (fr) Thieno-benzopyrannes et thiopyrano-benzopyrannes, produits intermediaires et procede pour leur obtention
CH628321A5 (en) Process for the preparation of derivatives of isobutyramide and medical composition containing these derivatives
CH472841A (fr) Composition stimulant la croissance et le développement des animaux, et procédé de préparation de cette composition
FR2602768A1 (fr) Derives de l'acide 2-(4,4'-difluoro benzhydryl thio) acetique, leurs procedes de preparation et leurs applications en therapeutique
FR2683817A1 (fr) Nouveaux derives d'alpha-amino n-pyridyl benzene propanamide, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2551755A1 (fr) Sels de dioxyde de benzothiazine cristallin et compositions pharmaceutiques les contenant
BE830510A (fr) Nouvelles -(beta-vinyloxyethyl)alpha-methyl beta-phenethylamines utiles notamment comme anorexiants
EP0430800A1 (fr) Nouvelles benzothiazolinones substituées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased